Clinical Trials Browser

NIH × Rhabdomyosarcoma × Immunoglobulin G × Clear all

NCT01222715 2017-05-05

Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma

Phase 2 Completed

87 enrolled 11 charts

Rhabdomyosarcoma, Sarcoma